Transparency Life Sciences snags $5 mln Series A
Transparency Life Sciences, a provider of digital drug development clinical services, has closed $5 million in Series A financing. New Ventures III led the round. In conjunction with the funding, New Ventures' Dr. Richard Warburg and Harry Glorikian will join the TLS board of directors.
15 February 2018•1 min read
